One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1200/jco.2014.32.15_suppl.5009
Copy DOI Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2014 |
 Citations: 46 |
Affiliation: Memorial Sloan Kettering Cancer Center, Roswell Park Cancer Institute, Fox Chase Cancer Center, Seattle Cancer Care Alliance, Bristol-Myers Squibb (France), Sidney Kimmel Comprehensive Cancer Center, Duke Medical Center, Bristol-Myers Squibb (United States), Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Northwestern University, Karmanos Cancer Institute, Medical University of South Carolina, Indiana Cancer Consortium, Indiana University – Purdue University Indianapolis, Cleveland Clinic, University of Michigan–Ann Arbor5009 Background: Nivolumab, a fully human IgG4 programmed death-1 immune checkpoint inhibitor antibody, restores T-cell immune activity and showed objective responses in mRCC in a phase I trial (NE...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
